EBOS GROUP LIMITED — Board/Management Information 2021

Sep 21, 2021

==> picture [144 x 42] intentionally omitted <==

22 September 2021

NZX/ASX Code: EBO

EBOS Animal Care CEO Appointment

EBOS Group Limited (“EBOS”) is pleased to announce the appointment of Julie Dillon as its new CEO Animal Care with effect from 1 November 2021. Ms Dillon joins EBOS following more than 25 years with Colgate-Palmolive where she gained broad experience as a leader across general management, brand marketing, digital, strategy and innovation.

After an extensive career internationally within many Colgate-Palmolive consumer products segments across the US, the UK and Europe, Ms Dillon returned to Australia in 2018 and most recently was Vice President and General Manager of the Colgate-Palmolive Division of Hill’s Pet Nutrition business for Australia, New Zealand and Greater Asia, based in Sydney.

John Cullity, EBOS Chief Executive Officer said, “Julie, with her wealth of broad experience in the pet and FMCG sectors, will be a great asset to our Animal Care business, which continues to experience strong growth. With increasing pet ownership and global trends such as the humanisation of pets and premiumisation of pet care products, I am very pleased to have Julie on board to steer our Animal Care business through this very exciting time”.

For further information please contact:

Martin Krauskopf General Manager, Mergers & Acquisitions and Investor Relations +61 3 9918 5555

Authorised for lodgement with NZX and ASX by Janelle Cain, General Counsel, EBOS Group Limited.

About EBOS Group

EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading Australasian animal care brand owner, product marketer and distributor.